Authors:
Korbonits, M
Chitnis, MM
Gueorguiev, M
Norman, D
Rosenfelder, N
Suliman, M
Jones, TH
Noonan, K
Fabbri, A
Besser, GM
Burrin, JM
Grossman, AB
Citation: M. Korbonits et al., The release of leptin and its effect on hormone release from human pituitary adenomas, CLIN ENDOCR, 54(6), 2001, pp. 781-789
Authors:
Korbonits, M
Bujalska, I
Shimojo, M
Nobes, J
Jordan, S
Grossman, AB
Stewart, PM
Citation: M. Korbonits et al., Expression of 11 beta-hydroxysteroid dehydrogenase isoenzymes in the humanpituitary: Induction of the type 2 enzyme in corticotropinomas and other pituitary tumors, J CLIN END, 86(6), 2001, pp. 2728-2733
Authors:
Korbonits, M
Bustin, SA
Kojima, M
Jordan, S
Adams, EF
Lowe, DG
Kangawa, K
Grossman, AB
Citation: M. Korbonits et al., The expression of the growth hormone secretagogue receptor ligand ghrelin in normal and abnormal human pituitary and other neuroendocrine tumors, J CLIN END, 86(2), 2001, pp. 881-887
Authors:
Kaltsas, G
Korbonits, M
Heintz, E
Mukherjee, JJ
Jenkins, PJ
Chew, SL
Reznek, R
Monson, JP
Besser, GM
Foley, R
Britton, KE
Grossman, AB
Citation: G. Kaltsas et al., Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors, J CLIN END, 86(2), 2001, pp. 895-902
Authors:
Kaltsas, GA
Korbonits, M
Isidori, AM
Webb, JAW
Trainer, PJ
Monson, JP
Besser, GM
Grossman, AB
Citation: Ga. Kaltsas et al., How common are polycystic ovaries and the polycystic ovarian syndrome in women with Cushing's syndrome?, CLIN ENDOCR, 53(4), 2000, pp. 493-500
Authors:
Putignano, P
Kaltsas, GA
Korbonits, M
Jenkins, PJ
Monson, JP
Besser, GM
Grossman, AB
Citation: P. Putignano et al., Alterations in serum protein levels in patients with Cushing's syndrome before and after successful treatment, J CLIN END, 85(9), 2000, pp. 3309-3312
Authors:
Skelly, RH
Korbonits, M
Grossman, A
Besser, GM
Monson, JP
Geddes, JF
Burrin, JM
Citation: Rh. Skelly et al., Expression of the pituitary transcription factor Ptx-1, but not that of the trans-activating factor Prop-1, is reduced in human corticotroph adenomasand is associated with decreased alpha-subunit secretion, J CLIN END, 85(7), 2000, pp. 2537-2542
Authors:
Korbonits, M
Little, JA
Forsling, ML
Tringali, G
Costa, A
Navarra, P
Trainer, PJ
Grossman, AB
Citation: M. Korbonits et al., The effect of growth hormone secretagogues and neuropeptide Y on hypothalamic hormone release from acute rat hypothalamic explants, J NEUROENDO, 11(7), 1999, pp. 521-528
Authors:
Korbonits, M
Kaltsas, G
Perry, LA
Putignano, P
Grossman, AB
Besser, GM
Trainer, PJ
Citation: M. Korbonits et al., The growth hormone secretagogue hexarelin stimulates the hypothalamo-pituitary-adrenal axis via arginine vasopressin, J CLIN END, 84(7), 1999, pp. 2489-2495
Authors:
Lidhar, K
Korbonits, M
Jordan, S
Khalimova, Z
Kaltsas, G
Lu, X
Clayton, RN
Jenkins, PJ
Monson, JP
Besser, GM
Lowe, DG
Grossman, AB
Citation: K. Lidhar et al., Low expression of the cell cycle inhibitor p27(Kip1) in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors, J CLIN END, 84(10), 1999, pp. 3823-3830